Insiders GT Biopharma, Inc.

Equities

GTBP

US36254L3087

Market Closed - Nasdaq Other stock markets 21:00:00 17/05/2024 BST			5-day change	1st Jan Change
3.12 ^USD	-4.59%		-6.17%	-59.22%

03-26	GT Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
02-01	GT Biopharma to Conduct 1-for-30 Reverse Stock Split; Shares Fall	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GT Biopharma, Inc. Announces Board Changes	04/05/23	CI
Beyond Air Affiliate Beyond Cancer Names Gavin Choy Chief Operating Officer	30/01/23	MT
Gt Biopharma Names Dr. Jeff Miller as Consulting Chief Medical Officer	14/12/22	CI
GT Biopharma, Inc. Announces Gregory Berk, President of Research & Development and Chief Medical Officer, Is no Longer Employee	13/12/22	CI
GT Biopharma, Inc. Appoints Alan L. Urban to Fill Vacant Seat on Board	10/06/22	CI
GT Biopharma, Inc. Announces CEO Changes	08/03/22	CI
GT Biopharma Appoints Manu Ohri as CFO	18/02/22	MT
GT Biopharma, Inc Appoints Manu Ohri as Chief Financial Officer	18/02/22	CI
GT Biopharma, Inc. Announces Resignation of Anthony Cataldo as Board of Director	21/12/21	CI
GT Biopharma, Inc. Announces Resignation of Michael Breen from the Registrant?s Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee	26/11/21	CI
GT Biopharma CEO Anthony Cataldo, CFO Michael Handelman Step Down to Pursue Other Interests; Shares Decline	08/11/21	MT
GT Biopharma Announces the Promotion of Dr. Gregory Berk to President of Research & Development and Chief Medical Officer	23/08/21	CI
GT Biopharma, Inc. Announces Resignation of Gregory Berk as Member of the Registrant’S Board of Directors	29/04/21	CI
GT Biopharma Announces Management Changes	26/04/21	CI
GT Biopharma, Inc. Announces Board Changes	19/01/21	CI
Dr. Greg Berk, M.D. Joins Board of Directors of GT Biopharma, Inc	19/11/20	CI
GT Biopharma, Inc. Appoints Michael Handelman as Chief Financial Officer	18/11/20	CI
GT Biopharma, Inc. Announces Advisory Board Appointments	13/10/20	CI
GT Biopharma, Inc. Appoints Jeffrey Miller, M.D. as Chief Medical Officer	20/08/19	CI
GT Biopharma, Inc. Announces Management Changes	21/03/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders GT Biopharma, Inc.

Equities

GTBP

US36254L3087

Insiders

Filters